These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 9616356)

  • 21. In utero diagnosis of long QT syndrome by magnetocardiography.
    Cuneo BF; Strasburger JF; Yu S; Horigome H; Hosono T; Kandori A; Wakai RT
    Circulation; 2013 Nov; 128(20):2183-91. PubMed ID: 24218437
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Time- and rate-dependent alterations of the QT interval precede the onset of torsade de pointes in patients with acquired QT prolongation.
    Gilmour RF; Riccio ML; Locati EH; Maison-Blanche P; Coumel P; Schwartz PJ
    J Am Coll Cardiol; 1997 Jul; 30(1):209-17. PubMed ID: 9207644
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of Microvolt T-Wave Alternans in Patients With Long QT Syndrome and Its Association With Torsade de Pointes.
    Takasugi N; Goto H; Takasugi M; Verrier RL; Kuwahara T; Kubota T; Toyoshi H; Nakashima T; Kawasaki M; Nishigaki K; Minatoguchi S
    Circ Arrhythm Electrophysiol; 2016 Feb; 9(2):e003206. PubMed ID: 26839386
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The QT interval and torsade de pointes.
    Moss AJ
    Drug Saf; 1999; 21 Suppl 1():5-10; discussion 81-7. PubMed ID: 10597863
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Torsades de Pointes.
    Viskin S
    Curr Treat Options Cardiovasc Med; 1999 Aug; 1(2):187-195. PubMed ID: 11096483
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SEVOFLURANE AS A CAUSE OF TORSADE DE POINTES IN PATIENT WITH THE LONG QT SYNDROME: Case Report.
    Choromanski DW; Amin S; Zestos MM
    Middle East J Anaesthesiol; 2016 Feb; 23(4):471-4. PubMed ID: 27382818
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Torsade de pointes during sevoflurane anesthesia in a child with congenital long QT syndrome.
    Saussine M; Massad I; Raczka F; Davy JM; Frapier JM
    Paediatr Anaesth; 2006 Jan; 16(1):63-5. PubMed ID: 16409532
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Torsade de pointes: the clinical considerations.
    Gowda RM; Khan IA; Wilbur SL; Vasavada BC; Sacchi TJ
    Int J Cardiol; 2004 Jul; 96(1):1-6. PubMed ID: 15203254
    [TBL] [Abstract][Full Text] [Related]  

  • 29. What is the minimal pacing rate that prevents torsades de pointes? Insights from patients with permanent pacemakers.
    Pinski SL; Eguía LE; Trohman RG
    Pacing Clin Electrophysiol; 2002 Nov; 25(11):1612-5. PubMed ID: 12494620
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Electrophysiologic mechanisms of the long QT interval syndromes and torsade de pointes.
    Tan HL; Hou CJ; Lauer MR; Sung RJ
    Ann Intern Med; 1995 May; 122(9):701-14. PubMed ID: 7702233
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of atropine on QT prolongation and torsade de pointes induced by intracoronary acetylcholine in the long QT syndrome.
    Furushima H; Niwano S; Chinushi M; Yamaura M; Taneda K; Washizuka T; Aizawa Y
    Am J Cardiol; 1999 Mar; 83(5):714-8. PubMed ID: 10080424
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Citalopram induced torsade de pointes, a rare life threatening side effect.
    Kanjanauthai S; Kanluen T; Chareonthaitawee P
    Int J Cardiol; 2008 Dec; 131(1):e33-4. PubMed ID: 17919753
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spontaneous sequences of onset of torsade de pointes in patients with acquired prolonged repolarization: quantitative analysis of Holter recordings.
    Locati EH; Maison-Blanche P; Dejode P; Cauchemez B; Coumel P
    J Am Coll Cardiol; 1995 Jun; 25(7):1564-75. PubMed ID: 7539014
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sevoflurane-associated torsade de pointes in a patient with congenital long QT syndrome genotype 2.
    Kumakura M; Hara K; Sata T
    J Clin Anesth; 2016 Sep; 33():81-5. PubMed ID: 27555138
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Torsade de pointes in NIDDM with long QT intervals.
    Abo K; Ishida Y; Yoshida R; Hozumi T; Ueno H; Shiotani H; Matsunaga K; Kazumi T
    Diabetes Care; 1996 Sep; 19(9):1010. PubMed ID: 8875100
    [No Abstract]   [Full Text] [Related]  

  • 36. Torsade de pointes.
    Roden DM
    Clin Cardiol; 1993 Sep; 16(9):683-6. PubMed ID: 7902224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bradycardia-associated torsade de pointes and the long-QT syndromes: a case report and review of the literature.
    Ashworth SW; Levsky ME; Marley CT; Kang CS
    Mil Med; 2005 May; 170(5):381-6. PubMed ID: 15974204
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Congenital and acquired long QT syndrome. Current concepts and management.
    Chiang CE
    Cardiol Rev; 2004; 12(4):222-34. PubMed ID: 15191637
    [TBL] [Abstract][Full Text] [Related]  

  • 39. QT interval prolongation and torsade de pointes.
    Patanè S; Marte F; Di Bella G
    Int J Cardiol; 2009 Jan; 131(2):e51-3. PubMed ID: 17689729
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adenosine induced torsades de pointes in a child with congenital long QT syndrome.
    Celiker A; Tokel K; Cil E; Ozkutlu S; Ozme S
    Pacing Clin Electrophysiol; 1994 Nov; 17(11 Pt 1):1814-7. PubMed ID: 7838793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.